Inotiv (NOTV) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue declined 32.8% year-over-year to $105.8M, mainly due to a 44.4% drop in RMS segment revenue from lower NHP sales.

• Net loss for Q3 was $26.1M versus net income of $0.4M last year; YTD net loss was $90.0M, including a $28.5M DOJ-related charge.

• Major legal matters resolved, including DOJ and U.S. Attorney's Office investigations, reducing future legal expenses and risk.

• Site optimization and transportation integration completed, enhancing efficiency and enabling new contracts.

• Substantial doubt exists about ability to continue as a going concern due to liquidity constraints and covenant risks.

Financial highlights

• Q3 2024 revenue: $105.8M (down from $157.5M in Q3 2023); nine-month revenue: $360.3M (down from $431.7M year-over-year).

• Q3 operating loss was $20.8M versus $8.8M operating income last year; net loss attributable to shareholders was $26.1M ($1.00/share).

• Adjusted EBITDA for Q3 was $0.1M (0.1% margin), down from $30.5M (19.4% margin) last year; YTD adjusted EBITDA was $12.8M (3.6% margin).

• Cash and equivalents at June 30, 2024, were $14.4M, down from $35.5M at September 30, 2023; total debt was $382.4M.

• Net cash used by operations for nine months was $4.4M, compared to $9.1M provided last year.

Outlook and guidance

• Management expects Q4 NHP sales volume to increase 120–130% over Q3 and exceed Q4 2023, with margin improvement anticipated in 2025 as higher-cost inventory is sold off.

• No financial guidance for fiscal 2024; plan to provide 2025 guidance once NHP contracts are finalized.

• Focus remains on operational efficiencies, cost reductions, and not relying solely on market recovery for improved results.

• Company is seeking further amendments to its Credit Agreement and may pursue additional financing.

• Risk of covenant non-compliance in Q4 if performance does not improve.